Drawing for CANCERPATH

USPTO serial 85279653

CANCERPATH

Reviewed by CopyMark Law Group

Reg. 4496772Status 710
Filing date
Status date
Registration date
Mar 18, 2014
Examiner
VOHRA, SANJEEV KUMAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CANCERPATH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MARK HARRISON

MARK HARRISON VENABLE LLPPO BOX 34385WASHINGTON, DC 20043-4385UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic agents, preparations and substances for medical and veterinary purposes; chemical reagents for medical or veterinary purposes; medical and veterinary testing preparations for investigation, testing, analysis, characterization or monitoring of biological material, namely, blood, plasma, serum, cells, saliva, urine, feces, semen, cerebral spinal fluid, tissue and skin; diagnostic preparations for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic preparations for medical and veterinary preparations in the fields of genetics, pharmacogenetics, oncology, cardiovascular medicine, respiratory ailments, serology, immunology, haematology, metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics and gynecology; chemical and biological preparations for testing for and in relation to genetics, pharmacogenetics, oncology, cardiovascular medicine, respiratory ailments, serology, immunology, haematology, metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics and gynecology; kits and assays for diagnosis and testing; kits and assays for diagnosis and testing, namely, medical kits comprising of assays for diagnosis and testing of biological material in the medical and veterinary fieldsSECTION 8 - CANCELLED—
010Diagnostic, screening and testing apparatus and instruments for use in diagnosing, screening testing, analyzing and monitoring of biological material for medical and veterinary purposes; chemical, biochemical and biological detection apparatus and instruments for obtaining, sampling, analyzing and monitoring of biological material for medical and veterinary purposes; diagnostic and testing apparatus and instruments for use in diagnosing, testing, analyzing and monitoring of biological material for medical and veterinary purposes; automated sampling, testing and diagnostic apparatus and instruments for use in the medical and veterinary fields, namely, for testing for and diagnosis and characterization of infectious diseases, blood grouping, virology, genetics, oncology, hepatology, pharmacogenetics, cardiovascular diseases, respiratory ailments, serology, immunology, hematology, metabolic disease, neurological disease, gastrointestinal disease, dermatology, urology, obstetrics and gynaecology, genetic diseases, bone disease and for orthodontics; diagnostic kits for medical and veterinary testing purposes consisting of apparatus and instruments and reagents for use in oncology testing; mobile apparatus and instruments for testing biological material in the medical and veterinary field; medical and veterinary apparatus and instruments for diagnostic and testing purposes in relation to antibodies, genetics, pharmacogenetics, oncology, cardiovascular medicine, and respiratory ailmentsSECTION 8 - CANCELLED—
016Printed matter, namely, paper labels; printed matter, namely, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, series of articles, reports, brochures, and product guides, all in the medical and veterinary fields; packaging for products, namely, packaging made from paper, cardboard, plastic bags and combinations thereof printed matter, namely, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, series of articles, reports, press releases, brochures and product guides all in the field of diagnostic, screening, analyzing, chemical, biochemical and biological detection, monitoring and control apparatus and instruments, and medical and veterinary apparatus and instruments in the medical and veterinary field; printed matter, namely, instructional leaflets, information sheets, and brochures all about diagnostic, screening, analyzing, chemical, biochemical and biological detection, monitoring and control apparatus and instruments, and medical and veterinary apparatus and instruments in the medical and veterinary fieldSECTION 8 - CANCELLED—
042Scientific research services; Industrial research in the field of diagnosis, screening, analysis and monitoring of solids, liquids, gases or biological material; biological, biochemical and chemistry research services; medical and veterinary research services; scientific, medical and veterinary research services in the field of diagnosis, screening, analysis and monitoring of biological material; scientific study and research in the fields of diagnosis, analysis, testing and monitoring of biological and chemical material for the purpose of identification and characterization of medical and veterinary conditions, illnesses and diseases; Medical and scientific research, namely, conducting clinical trials for the purpose of identification and characterization of patients before, during and after therapy or treatmentSECTION 8 - CANCELLED—
044Medical and veterinary services; medical and veterinary services relating to diagnostic testing; medical and veterinary services in the sampling, testing, screening and diagnosis of medical and veterinary conditions; medical and veterinary clinical diagnostic testing services; medical and veterinary consultancy services in the fields of medical and veterinary diagnosticsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 2020C8..CANCELLED SEC. 8 (6-YR)—
Mar 18, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 31, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2013NPUBNOTICE OF PUBLICATION—
Nov 26, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 22, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2013CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2013ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 28, 2013PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 16, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 12, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 4, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 4, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 4, 2013ALIEASSIGNED TO LIE—
Apr 3, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 10, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2012ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 8, 2012DOCKASSIGNED TO EXAMINER—
Sep 14, 2012PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 4, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 2, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 16, 2012ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 16, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2012MAILPAPER RECEIVED—
Feb 10, 2012CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2012ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 19, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2012MAILPAPER RECEIVED—
Jul 11, 2011CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2011DOCKASSIGNED TO EXAMINER—
May 5, 2011AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
May 4, 2011ALIEASSIGNED TO LIE—
May 3, 2011PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 2, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Apr 1, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance